about
Qinghaosu (Artemisinin): The Price of SuccessArtemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malariaArtesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malariaDihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaArtemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaArtemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaArtemisinin-based combination therapy for the treatment of uncomplicated Plasmodium vivax malaria and the prevention of relapsesDrugs for treating uncomplicated malaria in pregnant womenArtemisinin-based combination therapy for treating uncomplicated malariaSulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malariaArtesunate plus mefloquine versus mefloquine for treating uncomplicated malariaArtemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malariaArtemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malariaUnit-dose packaged drugs for treating malariaArtesunate-mefloquine for treating uncomplicated malariaReduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemetherThe benefits of artemisinin combination therapy for malaria extend beyond the individual patientMolecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEuropEffect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South AfricaSafety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial ResistanceMitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systemsTargeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working GroupMalaria: progress, perils, and prospects for eradicationSAM domain-dependent activity of PfTKL3, an essential tyrosine kinase-like kinase of the human malaria parasite Plasmodium falciparumRDTs as a source of DNA to study Plasmodium falciparum drug resistance in isolates from Senegal and the Comoros IslandsModelling malaria control.Randomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparumCost-effectiveness study of three antimalarial drug combinations in TanzaniaA randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant womenSafety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina FasoAn open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malariaMapping the spread of malaria drug resistanceAlternatively spliced transcripts and novel pseudogenes of the Plasmodium falciparum resistance-associated locus pfcrt detected in East African malaria patientsUnderstanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme.World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.Benefits of using multiple first-line therapies against malaria.Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studiesChanging patterns of clinical malaria since 1965 among a tea estate population located in the Kenyan highlandsCharacterization of the Alkylation Product of Heme by the Antimalarial Drug Artemisinin We are grateful to the CNRS for financial support, and to the French Ministery of Education for a PhD grant to J.C. Dr. Yannick Coppel (LCC-CNRS) is gratefully a
P2860
Q21032496-93916D44-19AA-4D73-8D27-74E4D3C3A824Q24188020-105E1034-A797-41FC-8B26-10AEF3DF42D5Q24198103-68AF4942-BD2C-4187-B070-4802EEFA43D6Q24201077-FCE8129E-F250-4F9E-A444-0D888B3FF9FBQ24202910-C974EF75-4CF1-4285-8B86-6BCCD9C3CD8EQ24235351-F8EBDA9C-3A06-425A-95DE-93D9D68CD2C9Q24236067-2530EAAA-E6F5-42DA-9C58-D84EECFC49D0Q24241218-DDD8A0C0-3002-4E00-B986-32D75216595BQ24241785-1612C662-C02D-40FC-B033-6851EF52ECF0Q24244592-21C8B7EA-5181-4242-B37E-AE80E38EC414Q24245347-CA21D062-6B0A-4AA7-98AD-A7620AFDFCE5Q24245437-DD01360C-952D-45BC-BAE2-445B4F956EF3Q24246332-57D573CD-0305-411C-88AA-71FC060D48D4Q24246943-48A4E250-4FF7-4ED6-91BA-F7C5B382FC19Q24247831-7B488F96-0B78-46CA-A4A9-FB75561FACE2Q24792020-C31685C0-734C-43EA-8757-803DEF75B98CQ24792313-CCFECCD3-DF5A-4FA3-8046-CF7130C99038Q24807035-32FB0BF2-715E-4FE1-B88B-8094B25A46CEQ24810617-284EFA55-0559-4256-81F1-3038E7BF7FD0Q24815501-AF6A10DE-4524-4313-85B0-C951FB5DD96DQ26864290-A134F80F-8A42-43D7-AB97-BC2D04E28CF6Q27000750-609A1810-DBB0-4A85-9995-D8910F299BCBQ27304660-EB45B639-CC29-4531-8A4D-9FD0E1FB1BC8Q27485634-9D9DA681-EC0C-4706-A909-F4B74DDF9011Q27974774-6B35F71F-21B7-409B-968C-BE97E19CF829Q28125925-20606862-04D2-45B5-8F9E-FD54560F0816Q28468756-535A8606-FE61-480B-94FC-80C3EFC28DE1Q28469026-CB14C61E-7E3A-42B9-8777-6B437CA01722Q28469054-D0BDB509-91DE-465B-B4C4-91078BC3A30AQ28469347-410D86A3-3F69-4121-BF78-2BDA8A776482Q28472182-C9DABE26-CE0C-4921-98A3-4F61DDB3903FQ28473004-97AD53F7-CFA1-4836-9A87-8301EA898AD0Q28475191-8EAC476F-B555-4386-B633-AA6846982C71Q28649722-55FED3F6-CA3E-4D7B-9E73-45865773305AQ30398478-9DE75371-0BF8-4CA1-911A-5A28BD16B455Q30483555-2DDB8657-7459-44FB-A9E4-5CE65C70DBCCQ30483653-FB6DBE38-3DED-4E97-B272-6F3FDF96E81AQ30568502-1BE64EAB-7619-4960-ABA5-A41FAD9F93DFQ30611242-F2306F43-7F23-4F93-A611-B32646F4E865Q31921497-EC40CFAE-40AA-4D28-AA6A-55D1354D9C30
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Averting a malaria disaster.
@en
Averting a malaria disaster.
@nl
type
label
Averting a malaria disaster.
@en
Averting a malaria disaster.
@nl
prefLabel
Averting a malaria disaster.
@en
Averting a malaria disaster.
@nl
P2093
P50
P1433
P1476
Averting a malaria disaster.
@en
P2093
B M Greenwood
M E Molyneux
R M Anderson
T E Taylor
T K Ruebush
P304
P356
10.1016/S0140-6736(98)07367-X
P407
P577
1999-06-01T00:00:00Z